College of Medicine / Research / Labs and Research Programs / Dr. Newcomer's Research

Dr. Newcomer's Research

John W. Newcomer, M.D., conducts clinical translational research focused on the improvement of cognitive, psychiatric and medical outcomes for at-risk individuals. His work in the last 10 years has aimed to improve screening and treatment of commonly occurring risk factors for cardiovascular disease and type 2 diabetes mellitus in populations with mental illness. He conducts experimental proof-of-concept studies, randomized clinical trials, large observational database studies, and studies that test interventions in large population-based samples, incorporating access to large clinical databases.

Dr. Newcomer has served as a principal investigator on research grants funded through the National Institutes of Health (NIH) for over 20 years, and has held a series of research leadership positions at Washington University in St. Louis, the University of Miami in Florida, and at FAU. Dr. Newcomer has received a number of honors and awards, including an Independent Scientist Award from the NIH and placement on the Thomson Reuters List of Highly Cited Researchers in 2014, with an h-index of 52. Dr. Newcomer has served as a longstanding reviewer for the NIH and other funding agencies.

Most recently, Dr. Newcomer has worked on a series of projects to increase screening and treatment of cardiometabolic risk factors among the mentally ill population. In addition, he continues to study new approaches to improve outcomes in patients with psychiatric disorders, with particular interest in improving the safety and tolerability of available treatments.

Last Modified 3/7/18